StoxCrop Life Science Limited
NSE: CLSL · Unclassified
Ask the data
Instant answers about Crop Life Science Limited — computed from its filings, no language modelPrice & valuation
split & bonus adjusted · pick a metric and rangeAnnual performance
annual · ₹ crore · line = operating margin| FY24 | FY25 | FY26 | |
|---|---|---|---|
| Revenue | 198.6 | 200.6 | 207.2 |
| EBITDA | 12.6 | 16.4 | 17.8 |
| Operating margin | 6.4% | 8.2% | 8.6% |
| Interest | 3.4 | 4.8 | 5.4 |
| Depreciation | 3.2 | 4.8 | 4.9 |
| Profit before tax | 8.1 | 7.8 | 9.2 |
| Tax | 2.1 | 2.2 | 2.7 |
| Net profit | 6.0 | 0.0 | 0.0 |
| EPS ₹ | 3.54 | 3.15 | 3.79 |
| Operating cash flow | -8.3 | -2.1 | -7.6 |
| Capex | 7.4 | 3.9 | 1.9 |
| Dividend paid | 0.0 | 0.0 | 0.0 |
| Total assets | — | 181.7 | 207.9 |
| Equity | — | 77.5 | 84.2 |
Half-yearly performance
last 4 half years · ₹ crore| H1 FY25 | H2 FY25 | H1 FY26 | H2 FY26 | |
|---|---|---|---|---|
| Revenue | 106.3 | 94.2 | 120.3 | 86.9 |
| Operating profit | 8.4 | 8.0 | 8.0 | 9.8 |
| Operating margin | 7.9% | 8.5% | 6.6% | 11.3% |
| Other income | 0.0 | 0.9 | 0.8 | 1.0 |
| Interest | 2.3 | 2.5 | 2.8 | 2.6 |
| Depreciation | 2.4 | 2.5 | 2.2 | 2.7 |
| Profit before tax | 3.8 | 4.0 | 4.0 | 5.3 |
| Tax | 1.0 | 1.2 | 1.1 | 1.6 |
| Net profit | 0.0 | 0.0 | 0.0 | 0.0 |
| EPS ₹ | 2.21 | 1.54 | 2.31 | 1.48 |
| Revenue YoY | — | — | 13.1% | -7.8% |
Returns & margins
trailing-twelve-month, per half year| H2 FY25 | H1 FY26 | H2 FY26 | |
|---|---|---|---|
| ROE | 0.0% | 0.0% | 0.0% |
| ROCE | 10.6% | 9.8% | 10.6% |
| Net margin | 0.0% | 0.0% | 0.0% |
| EBITDA margin | 8.2% | 7.5% | 8.6% |
| Debt / equity | 0.52 | 0.68 | 0.64 |
| Interest coverage | 2.64 | 2.51 | 2.70 |
| Asset turnover | 1.10 | 0.98 | 1.00 |
Balance sheet
equity vs borrowings over time · ₹ crore| SEP '24 | MAR '25 | SEP '25 | MAR '26 | |
|---|---|---|---|---|
| Share capital | 17.1 | 17.1 | 17.1 | 17.1 |
| Other equity / reserves | 57.7 | 60.3 | 63.4 | 67.1 |
| Total equity | 74.9 | 77.5 | 80.5 | 84.2 |
| Borrowings | 40.3 | 40.6 | 55.0 | 53.6 |
| Current liabilities | 147.2 | 92.8 | 128.0 | 113.8 |
| Non-current liabilities | 8.8 | 7.6 | 7.4 | 6.2 |
| Total assets | 234.7 | 181.7 | 219.5 | 207.9 |
| Property, plant & equipment | 31.6 | 31.9 | 25.9 | 24.9 |
| Capital work-in-progress | 0.0 | 0.0 | 3.2 | 0.0 |
| Investments | 1.0 | 0.6 | 0.0 | 0.6 |
| Inventories | 53.1 | 48.9 | 69.5 | 70.6 |
| Receivables | 117.1 | 69.3 | 81.0 | 74.1 |
| Cash & equivalents | 0.8 | 0.8 | 1.8 | 1.2 |
Cash flow
annual · ₹ crore · line = free cash flow| FY24 | FY25 | FY26 | |
|---|---|---|---|
| Cash from operations | -8.3 | -2.1 | -7.6 |
| Cash from investing | -3.4 | -3.5 | 1.6 |
| Cash from financing | 13.4 | 4.2 | 21.9 |
| Capex | 7.4 | 3.9 | 1.9 |
| Free cash flow | -15.8 | -6.0 | -9.6 |
| Dividends paid | 0.0 | 0.0 | 0.0 |
Where the assets sit
Mar '26 · ₹ crorePeer comparison
largest in Unclassified · this company in bold| Company | Market cap ₹cr | Price | P/E | P/B | ROE |
|---|---|---|---|---|---|
| Avantel Limited | 36,86,04,549 | 138.69 | — | 1059360.68 | 0.0% |
| Ducol Organics And Colours Limited | 19,55,275 | 120.00 | — | 20089.13 | 0.0% |
| Jio Platforms Limited | 12,57,181 | 1,406.40 | — | 3.57 | — |
| SBI Funds Management Limited | 1,01,750 | 499.55 | — | — | — |
| Tamilnadu Telecommunication Limited | 91,314 | 9.93 | — | — | — |
| Manipal Health Enterprises Limited | 76,294 | 646.70 | — | — | — |
| INDO-MIM Limited | 59,042 | 1,219.50 | — | — | — |
| AvenuesAI Limited | 45,138 | 129.25 | 153.6 | 9.51 | 6.2% |
| Dhoot Transmission Limited | 32,761 | 1,601.60 | — | 8.11 | — |
| 3M India Limited | 31,071 | 27,570.00 | 53.8 | 17.57 | 32.7% |
| Crop Life Science Limited | 171 | 99.50 | — | 2.02 | 0.0% |
StoxGud checklist: Neutral setup · 5/10
- Price above 50-day average
- Price above 200-day average
- 50-day average above 200-day (uptrend)
- RSI in healthy 40–70 zone
- Positive 1-year return
- Return on equity above 15%
- Debt to equity below 1
- Revenue growing year on year
- Net profit margin above 10%
- P/E below industry median
A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.
Returns & technicals
FAQs
What is the share price of Crop Life Science Limited?
Crop Life Science Limited (CLSL) closed at ₹99.50 on NSE on 06 Nov 2026.
What is the market cap of Crop Life Science Limited?
₹171 crore at the latest close.
How fast is Crop Life Science Limited growing?
Crop Life Science Limited: Latest-half-year revenue is down 7.8% year on year.
How profitable is Crop Life Science Limited?
On a trailing-twelve-month basis return on equity is 0.0%, return on capital employed 10.6%, operating margin 8.6%, net margin 0.0%.
How much debt does Crop Life Science Limited have?
Crop Life Science Limited is moderately geared: debt to equity is 0.64 with borrowings of ₹54 cr against cash of ₹1 cr (balance sheet of 2026-03-31). Operating profit covers interest 2.7 times.
Financials parsed from Crop Life Science Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Half-yearly from H1 FY25, annual from FY24, balance sheet from Sep '24. * = derived (full year minus the other half). This company is on NSE's SME platform and reports results half-yearly. Information only, not investment advice.